| Autor: |
Omar OMF; Center for Vascular Biology, University of Connecticut Medical School, Farmington CT., Kimble AL; Center for Vascular Biology, University of Connecticut Medical School, Farmington CT., Cheemala A; Center for Vascular Biology, University of Connecticut Medical School, Farmington CT., Tyburski JD; Center for Vascular Biology, University of Connecticut Medical School, Farmington CT., Pandey S; Center for Vascular Biology, University of Connecticut Medical School, Farmington CT., Wu Q; Department of Pathology, University of Connecticut Medical School, Farmington CT., Reese B; Center for Genome Innovation, University of Connecticut, Storrs CT., Jellison ER; Department of Immunology, University of Connecticut Medical School, Farmington CT., Li Y; Department of Molecular Biology and Biophysics, Farmington CT., Hao B; Department of Molecular Biology and Biophysics, Farmington CT., Yan R; Department of Neuroscience, University of Connecticut Medical School, Farmington CT., Murphy PA; Center for Vascular Biology, University of Connecticut Medical School, Farmington CT.; Department of Immunology, University of Connecticut Medical School, Farmington CT.; Department of Neuroscience, University of Connecticut Medical School, Farmington CT. |
| Abstrakt: |
Despite the importance of the endothelium in the regulation of the blood brain barrier (BBB) in aging and neurodegenerative disease, difficulties in extracting endothelial cell (EC) nuclei have limited analysis of these cells. In addition, nearly all Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD), and a large portion of Alzheimer's Disease (AD) exhibit neuronal TDP-43 aggregation, leading to loss of nuclear function, but whether TDP-43 is similarly altered in human BBB ECs is unknown. Here we utilize a novel technique for the enrichment of endothelial and microglial nuclei from human cortical brain tissues, combined with inCITE-seq, to analyze nuclear proteins and RNA transcripts in a large cohort of healthy and diseased donors. Our findings reveal a unique transcriptional signature in nearly half of the capillary endothelial cells across neurodegenerative states, characterized by reduced levels of nuclear β-Catenin and canonical downstream genes, and an increase in TNF/NF-kB target genes. We demonstrate that this does not correlate with increased nuclear p65/NF-kB, but rather a specific loss of nuclear TDP-43 in these disease associated ECs. Comparative analysis in animal models with targeted disruption of TDP-43 shows that this is sufficient to drive these transcriptional alterations. This work reveals that TDP-43 is a critical governor of the transcriptional output from nuclear p65/NF-kB, which has paradoxical roles in barrier maintenance and also barrier compromising inflammatory responses, and suggests that disease specific loss in ECs contributes to BBB defects observed in the progression of AD, ALS and FTD. |
